Hollmen 2002.

Methods	RCT Study aim clearly defined: yes Blinded assessor of primary outcome: not stated Double blind study; yes Participants comparable at baseline for age: yes Sex: not stated Duration of complaint: not stated Inclusion and exclusion criteria specified: yes Interventions well described: yes Assessment of compliance: not stated Intention to treat analysis: yes A Priori sample size calculation: yes Fungi identified: not stated Distribution of species between groups: not stated Adverse events reported: not stated Number of drop outs stated: yes
Participants	Total evaluable sample size: 70 Exclusion criteria: less than 12 years of age. Inclusion criteria; tinea pedis. Treatment setting Six centres (three Belgium, three Finland)
Interventions	a. Terbinafine 1% gel Duration: Seven days Frequency: applied once daily b. Placebo Duration: seven days Frequency: applied once daily
Outcomes	Primary outcome; Mycological cure Minimal signs of clinical disease erythema, desquamation, pruritis < 2 with no individual score > 1 and a severity score for pustulation, encrustation, and vesiculation of 0 Clinical cure; 6 symptoms assessed; 0= absent, 3= severe
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear